Klinik und Poliklinik für Urologie und Kinderurologie
Klinikum / Johannes Gutenberg-Universität Mainz
Surcel, Cristian; Dotzauer, Robert; Mirvald, Cristian et al.
Current role of intraoperative cell salvage techniques in the management of renal tumors with level III and IV inferior vena cava thrombus extensionTHERAPEUTIC ADVANCES IN UROLOGY. Bd. 16. 2024
Aitken, K. J.; Schroder, Annette; Haddad, Ahmed et al.
Epigenetic insights to pediatric uropathology: Celebrating the fundamental biology vision of Tony KhouryJOURNAL OF PEDIATRIC UROLOGY. Bd. 20. 2024 S. S43-S57
Schneider, Francois; Chen, Haotian; Compton, Richard G. et al.
Exploring Data-Based Machine Learning Algorithms for the Evaluation of Disease Stage, Treatment-response and Overall Survival in Pancreatic adenocarcinomaONCOLOGY RESEARCH AND TREATMENT. Bd. 47. 2024 S. 22-22
Souschek, Fabio; Schroeder, Annette; Schmeh, Isabella et al.
Giant prostatic utricle cyst in a newborn with Simpson-Golabi-Behmel syndrome: Voiding cysturethrography essential for the diagnosisROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN. Bd. 197. H. 03. 2024 S. 322-324
Markowitsch, Sascha D.; Pham, Thao; Rutz, Jochen et al.
Growth of Renal Cancer Cell Lines Is Strongly Inhibited by Synergistic Activity of Low-Dosed Amygdalin and SulforaphaneNUTRIENTS. Bd. 16. H. 21. 2024
Duwe, Gregor; Boehm, Katharina; Becker, Gerrit et al.
Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvementWORLD JOURNAL OF UROLOGY. Bd. 42. H. 1. 2024
Brandt, Maximilian P.; Vakhrusheva, Olesya; Hackl, Hubert et al.
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerAMERICAN JOURNAL OF PATHOLOGY. Bd. 194. H. 11. 2024 S. 2150-2162
Tsaur, Igor; Brandt, Maximilian Peter Johannes Karl; Goekkurt, Eray et al.
INSIGHT-005: A new stratum of the explorative, open-labeled, phase I INSIGHT study to evaluate the feasibility and safety, as well as preliminary efficacy, of subcutaneous injections with IMP321 (eftilagimod alpha) in combination with PD-L1 inhibitor (avelumab) for metastatic or unresectable locally advanced urothelial carcinoma (UC)-IKF-s614JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
Duwe, Gregor; Kauth, Verena; Moench, Kerstin et al.
KITTU: Artificial intelligence supports multidisciplinary cancer conferences - first steps towards revolutionizing clinical decision making in oncologyONCOLOGY RESEARCH AND TREATMENT. Bd. 47. 2024 S. 20-20
Stelmach, Ramona; Schlack, Katrin; Muhle, Clemens et al.
Lenvatinib plus Pembrolizumab as first-line treatment in patients with advanced renal cell carcinoma (aRCC) - real world data from a retrospective multi- center analysisONCOLOGY RESEARCH AND TREATMENT. Bd. 47. 2024 S. 88-88